Goodwill Impairment Testing: IFRS vs US GAAP — A Side-by-Side Comparison for Finance Teams

Goodwill is one of the largest and most scrutinized assets on corporate balance sheets worldwide. For companies that have grown through acquisition — whether a US-listed tech company, a UK private equity-backed platform, or an ASX-listed industrial group — goodwill impairment testing is an annual obligation that carries significant financial reporting risk, audit complexity, and board-level visibility.

Yet the rules governing goodwill impairment testing differ meaningfully between US GAAP (ASC 350) and IFRS (IAS 36) — and the differences matter practically for multinational groups, cross-border acquirers, and finance teams that must navigate both frameworks simultaneously.

This complete guide breaks down exactly how goodwill impairment testing works under each standard, where the frameworks diverge, and what that means for your financial reporting in 2026. It also explains how Synpact Consulting delivers audit-ready goodwill impairment analyses in 48–72 hours for clients across the US, UK, and Australia.

What Is Goodwill and Why Does It Need to Be Tested for Impairment?

Goodwill arises in a business combination when the consideration paid exceeds the fair value of the net identifiable assets acquired. It represents the premium paid for synergies, assembled workforce, market position, and other unidentifiable value drivers that cannot be separately recognized as discrete intangible assets.

Under both IFRS and US GAAP, goodwill is:

Not amortized — unlike other finite-lived intangible assets, goodwill has an indefinite life and is carried at cost less accumulated impairment losses
Tested for impairment — at least annually, and whenever a triggering event suggests value may have declined
Subject to an impairment write-down if the carrying value exceeds the recoverable amount (IFRS) or fair value (US GAAP)
Never written back up — once an impairment charge is recognized, it cannot be reversed under either standard

Goodwill impairment is a non-cash charge, but its consequences are very real: it reduces reported earnings, equity, and key financial ratios — often triggering analyst downgrades, investor questions, and covenant concerns with lenders.

Getting impairment testing right — with a rigorous, defensible analysis — protects companies from both undetected impairment (and its eventual, larger write-down) and unnecessary impairment charges from insufficiently robust analyses.

The Two Frameworks at a Glance

Before diving into methodology, here is a high-level orientation to the two standards:

Feature	IFRS (IAS 36)	US GAAP (ASC 350)
Governing standard	IAS 36 Impairment of Assets	ASC 350-20 Intangibles — Goodwill and Other
Unit of account	Cash Generating Unit (CGU)	Reporting Unit (RU)
Impairment test structure	Single-step recoverable amount test	Optional qualitative step + quantitative fair value test
Measure of recoverable amount	Higher of VIU and FVLCD	Fair value of reporting unit
Goodwill allocation	Allocated to CGUs or groups of CGUs	Allocated to reporting units
Impairment loss calculation	Carrying amount minus recoverable amount	Carrying amount minus fair value (capped at goodwill balance)
Reversal of impairment	Not permitted for goodwill	Not permitted
Frequency of testing	Annual + trigger-based	Annual + trigger-based
Private company alternative	N/A	ASC 350-20 allows amortization over 10 years (private companies only)

IFRS Goodwill Impairment Testing: IAS 36 in Detail

The Cash Generating Unit (CGU)

Under IAS 36, goodwill must be allocated to Cash Generating Units (CGUs) — the smallest identifiable group of assets that generates cash inflows largely independent of the cash inflows from other assets or groups of assets.

The CGU is the unit of account for the impairment test. Goodwill cannot float at a corporate level — it must be allocated to the CGUs or groups of CGUs that are expected to benefit from the synergies of the business combination. This allocation is made at acquisition date and remains in place unless the CGU structure changes.

Practical implication: If an acquisition was expected to benefit multiple CGUs (e.g., a horizontal integration across geographies), goodwill must be systematically allocated to each benefiting CGU — not simply left at the consolidated group level. This allocation is both technically complex and consequential for subsequent impairment testing.

The Single-Step Recoverable Amount Test

IAS 36 uses a single-step test: compare the carrying amount of the CGU (including allocated goodwill) against its recoverable amount.

Recoverable Amount = Higher of:

1. Value in Use (VIU) The present value of the future cash flows expected to be derived from the CGU, discounted at a pre-tax rate reflecting current market assessments of the time value of money and the risks specific to the asset. Key components:

Cash flow projections based on reasonable and supportable assumptions — management’s approved budgets/forecasts covering a maximum of five years (unless a longer period is justified)
Terminal value beyond the explicit forecast period, using a steady-state growth rate that does not exceed the long-term average growth rate for the CGU’s market
Pre-tax discount rate — a critical and frequently contentious aspect; IAS 36 requires a pre-tax rate, but practitioners often derive this from a post-tax WACC using iterative adjustment

2. Fair Value Less Costs of Disposal (FVLCD) The amount obtainable from selling the CGU in an arm’s length transaction between knowledgeable, willing parties — less the costs of disposal. Measured using the IFRS 13 fair value hierarchy.

If the recoverable amount exceeds the carrying amount, no impairment is recognized. If the carrying amount exceeds the recoverable amount, the difference is recognized as an impairment loss — allocated first to reduce the carrying amount of any goodwill allocated to the CGU, then to other assets on a pro-rata basis.

IFRS Impairment Triggers

In addition to the mandatory annual test, IAS 36 requires an impairment test whenever there is an indication of impairment — an external or internal trigger suggesting value may have declined. Examples include:

External indicators:

Significant decline in market value of the CGU’s assets
Adverse changes in the technological, market, economic, or legal environment
Increase in market interest rates (raises discount rate, reducing VIU)
Carrying amount of net assets exceeds market capitalization

Internal indicators:

Evidence of physical damage or obsolescence
Significant adverse changes in how the asset is used
Operating losses or significant cash flow shortfalls versus plan
Planned restructuring or discontinuation of the CGU

US GAAP Goodwill Impairment Testing: ASC 350 in Detail

The Reporting Unit

Under ASC 350, goodwill is allocated to Reporting Units (RUs) — operating segments or one level below an operating segment (components), provided the component is a business for which discrete financial information is available and reviewed by segment management.

Reporting units are similar in concept to IFRS CGUs, but the boundaries can differ — particularly for large diversified groups where segment definitions under ASC 280 do not align cleanly with the economic unit for which cash flows are managed.

The Two-Step Testing Framework (Now Simplified to One Quantitative Step)

The FASB simplified the US GAAP goodwill impairment test in 2017 through ASU 2017-04, eliminating the former Step 2 (which required a hypothetical purchase price allocation). The current framework is:

Step 0 — Optional Qualitative Assessment (“Step Zero”) Before performing any quantitative analysis, companies may assess qualitative factors to determine whether it is more likely than not (probability > 50%) that the fair value of a reporting unit is less than its carrying amount. If the conclusion is that impairment is not more likely than not, no further testing is required.

This is the qualitative “screening” step — often referred to as the optional qualitative assessment or “Step Zero.” It is not required; companies can bypass it and proceed directly to quantitative testing.

Relevant qualitative factors include:

Macroeconomic conditions (market interest rates, credit availability, GDP growth)
Industry and market conditions (competitive environment, market multiples)
Cost factors (raw materials, labour)
Overall financial performance vs. plan
Reporting unit-specific events (management changes, customer losses, litigation)
Changes in carrying amount since last fair value measurement

Step 1 — Quantitative Fair Value Test If the qualitative assessment concludes that impairment is more likely than not (or if Step Zero is bypassed), the company performs a quantitative test:

Compare the fair value of the reporting unit to its carrying amount (including goodwill).

If fair value exceeds carrying amount → no impairment. If carrying amount exceeds fair value → impairment loss = carrying amount minus fair value, capped at the total goodwill balance of the reporting unit.

Fair value of the reporting unit is typically estimated using:

Income approach — DCF analysis using projected free cash flows and a risk-adjusted discount rate (WACC)
Market approach — guideline public company multiples (EV/EBITDA, EV/Revenue) applied to reporting unit metrics
Both approaches, weighted based on relevance and reliability

Unlike IFRS, US GAAP uses a post-tax discount rate in the DCF analysis — an important methodological distinction when reconciling analyses across both frameworks.

US GAAP Impairment Triggers

ASC 350-20 requires an impairment test whenever events or changes in circumstances indicate it is more likely than not that a reporting unit’s fair value has fallen below its carrying amount. These “triggering events” include:

Significant adverse change in legal, regulatory, or business climate
Significant adverse change in expected financial performance
Significant decline in market capitalization (relevant for publicly listed companies)
Unanticipated competition or loss of key personnel
Change in reporting unit composition or disposition of all or part of a reporting unit
Recognition of goodwill impairment by a subsidiary

The 7 Key Differences Between IFRS and US GAAP Goodwill Impairment Testing

For finance teams navigating both frameworks — common for UK or Australian subsidiaries of US-listed groups, or for companies with dual listings — these differences are critical:

1. Unit of Account: CGU vs. Reporting Unit

IFRS CGUs are defined based on independent cash flows; US GAAP Reporting Units are defined based on segment management structure. In practice, US GAAP Reporting Units tend to be larger aggregations than IFRS CGUs — meaning IFRS testing is often more granular and more likely to identify localized impairment.

2. Measurement of Recoverable Amount

IFRS uses the higher of VIU and FVLCD — companies can choose whichever measure is most favorable. US GAAP uses fair value only — there is no equivalent of VIU as an alternative measurement basis.

This matters when a CGU/RU has a fair value lower than its VIU — possible for assets with high value-in-use to the specific owner (e.g., strategic synergies) but lower market value to a hypothetical third-party buyer. Under IFRS, using VIU can avoid an impairment that US GAAP would require.

3. Discount Rate: Pre-Tax vs. Post-Tax

IAS 36 requires a pre-tax discount rate for VIU calculations. ASC 350 uses a post-tax discount rate for the fair value DCF. This creates a mechanical difference in the discount rate applied — and is one of the reasons IFRS and US GAAP impairment analyses for the same entity can yield different conclusions.

4. Cash Flow Projections: Management Budgets vs. Market Participant Assumptions

IAS 36 VIU uses entity-specific assumptions — management’s own cash flow projections. ASC 350 fair value uses market participant assumptions — what a hypothetical buyer would assume. This is a fundamental conceptual difference: IFRS VIU captures the value to the current owner; US GAAP fair value captures what the market would pay.

In practice, management projections and market participant assumptions often differ — particularly in post-acquisition integration scenarios where synergies have been achieved that an independent buyer might not value equally.

5. Terminal Growth Rate Constraints

IAS 36 explicitly states that the long-term growth rate used for periods beyond the explicit forecast period should not exceed the long-term average growth rate for the products, industries, or countries in which the entity operates — a ceiling on terminal growth rate. ASC 350 has no equivalent explicit ceiling, though the reasonableness of terminal growth rates is subject to auditor scrutiny.

6. Qualitative Screening

US GAAP explicitly provides for a qualitative screening step (Step Zero) that allows companies to avoid a full quantitative analysis if qualitative factors indicate impairment is not more likely than not. IFRS has no formal equivalent — IAS 36 requires a recoverable amount test whenever there is an indication of impairment, with no formal qualitative bypass mechanism.

7. Private Company Alternative (US GAAP Only)

Under US GAAP, eligible private companies may elect to amortize goodwill over a period not exceeding 10 years under the Private Company Council (PCC) alternative. If this election is made, the company performs a simplified impairment test only when a triggering event occurs — not annually. This alternative is not available under IFRS.

What a High-Quality Goodwill Impairment Analysis Looks Like

Whether under IFRS or US GAAP, a goodwill impairment analysis that will withstand auditor scrutiny requires:

Robust CGU / Reporting Unit Definition Documented rationale for CGU/RU boundaries, with evidence that the unit is the smallest level at which cash flows are independently monitored and generated.

Credible Cash Flow Projections Projections based on management-approved budgets and forecasts, with clear documentation of key assumptions (revenue growth rates, margin trajectory, capital expenditure) and their basis. Auditors scrutinize whether projections are consistent with historical performance, industry outlook, and prior-year impairment test assumptions.

Defensible Discount Rate The discount rate is typically the single most contentious assumption in a goodwill impairment analysis. It must be derived from observable market data (risk-free rate, equity risk premium, beta, size premium, specific risk premium) and clearly documented. Under IFRS, the pre-tax vs. post-tax iteration must be shown.

Terminal Value Methodology Explicit justification of the terminal growth rate — benchmarked against long-term GDP growth, industry growth, and inflation expectations. Sensitivity analysis showing the impact of ±1% changes in discount rate and terminal growth rate is standard practice and expected by auditors.

Sensitivity Analysis & Headroom Documentation of how much the key assumptions (discount rate, revenue growth, EBITDA margin) would need to deteriorate before an impairment would be triggered. This “headroom” analysis is a central part of the IFRS IAS 36 disclosures and is increasingly expected by US GAAP auditors as well.

Full Documentation A written report covering: unit definition, carrying amount, methodology, assumptions, calculations, conclusion, sensitivity analysis, and disclosure support. Produced at a level of detail sufficient for the reporting entity’s auditors to independently review and concur.

Synpact’s goodwill & intangible impairment testing service delivers all of the above — for both IAS 36 and ASC 350 frameworks — with standard delivery in 48–72 hours for straightforward CGU/RU analyses.

When Does Goodwill Impairment Become a Crisis? Lessons for CFOs

Goodwill impairment charges have been among the largest single non-cash charges in corporate history — often signaling that an acquisition was overpaid or that post-acquisition performance has disappointed. For CFOs, the goal is not to avoid impairment testing but to conduct it rigorously enough that impairment is identified early — and that when a charge is required, it is sized correctly and communicated proactively.

The risk of under-testing: Companies that routinely clear their impairment tests with thin headroom, using optimistic projections that are never subsequently achieved, are accumulating unrecognized impairment. When the eventual write-down comes — often triggered by a market downturn or an acquisition that fails to deliver — it is larger and more disruptive than if impairment had been recognized incrementally.

The risk of over-testing: Conversely, companies that apply excessively conservative assumptions may recognize impairment that is not economically justified — destroying shareholder value through accounting conservatism rather than economic reality.

The solution is a rigorous, balanced, well-documented analysis — supported by independent valuation expertise that can defend its conclusions to auditors, investors, and regulators.

How Synpact Supports Goodwill Impairment Testing for US, UK & Australian Clients

Synpact Consulting’s goodwill & intangible impairment testing practice serves clients across three primary use cases:

Annual Impairment Testing Full IAS 36 or ASC 350 impairment analysis for all CGUs/RUs carrying goodwill — delivered on a recurring annual basis, with roll-forward efficiency for clients who engage us year-over-year.

Triggering Event Assessment Rapid-turnaround impairment assessment when a triggering event occurs mid-year — typically required within the quarter in which the trigger is identified. Our 48-hour delivery capability is particularly valuable in these time-sensitive situations.

Post-Acquisition Impairment Support For recently completed acquisitions, we provide the PPA foundation (through our Business Combination & PPA service) and then deliver recurring impairment testing on the resulting goodwill balance — ensuring consistency between acquisition accounting and ongoing reporting.

Multi-Jurisdiction Support For groups reporting under both IFRS and US GAAP — or for US-listed companies with Australian or UK subsidiaries — we deliver parallel analyses under both frameworks, with a clear reconciliation of the differences in methodology and conclusion.

We also support the broader financial reporting valuation ecosystem — including fair value measurement under ASC 820 / IFRS 13, stock-based compensation under ASC 718, and lease accounting valuations under ASC 842 / IFRS 16.

Cost Comparison: Goodwill Impairment Testing — India vs. Local Providers

Provider	Typical Fee (Per CGU/RU Analysis)	Turnaround
Big Four (US / UK / Australia)	$15,000–$50,000+ per RU	4–8 weeks
Mid-tier valuation firm	$8,000–$20,000 per RU	3–5 weeks
India-based specialist (Synpact)	$2,000–$8,000 per RU	48 hrs–5 days

For companies with multiple CGUs or reporting units — common for large acquirers or diversified groups — the cumulative savings from outsourcing impairment testing to Synpact are substantial. A group with five reporting units that would pay $25,000 per unit at a Big Four firm ($125,000 total) can receive the same quality of analysis from Synpact for $20,000–$35,000 — saving $90,000–$105,000 per annual testing cycle.

Frequently Asked Questions — Goodwill Impairment Testing

Q: Under IFRS, can I always use Value in Use to avoid showing an impairment? A: VIU must be based on reasonable and supportable assumptions — it is not a mechanism to simply avoid impairment by projecting optimistic cash flows. Auditors will challenge VIU projections that are inconsistent with historical performance or external market conditions. If VIU is used, all underlying assumptions must be fully documented and defensible.

Q: We are a US GAAP company but have an Australian subsidiary that reports under IFRS. Do we need separate impairment tests? A: Yes. The subsidiary’s IFRS financial statements require an IAS 36 analysis at the CGU level. The US GAAP consolidated group requires an ASC 350 analysis at the Reporting Unit level. These may yield different conclusions due to framework differences. Synpact delivers both analyses in parallel, with a clear reconciliation of differences.

Q: How often do goodwill impairment charges actually result from the annual test? A: The majority of annual tests result in no impairment — the recoverable amount or fair value exceeds carrying amount, often with meaningful headroom. However, triggering events — particularly in economic downturns, interest rate spikes, or post-acquisition underperformance — can require mid-year tests that result in charges. Maintaining current, robust impairment analyses means charges, when required, are better anticipated and disclosed.

Q: What is the most common cause of goodwill impairment charges? A: The most common causes are: (1) acquisition at an overvalued price relative to subsequently realized synergies, (2) deterioration of the acquired business’s competitive position post-acquisition, (3) increase in discount rates (which reduces the present value of future cash flows — highly relevant in the 2022–2025 rate environment), and (4) market multiple compression reducing fair value estimates.

Q: Can Synpact handle impairment testing for a company with goodwill in multiple geographies? A: Yes. Multi-geography goodwill impairment is one of our most common engagement types, particularly for UK and Australian groups with operations across multiple markets. We handle CGU-level analyses in each geography, with consistent methodology and a consolidated summary for the group auditor.

Q: How do I get started with Synpact’s impairment testing service? A: Book a free 30-minute strategy call to discuss your CGU/RU structure, reporting framework (IFRS or US GAAP), timeline, and data availability. We will confirm scope, fees, and delivery timeline within 24 hours of the call.

Get Your Goodwill Impairment Analysis Done in 48–72 Hours

Whether you are approaching your annual goodwill impairment testing deadline, responding to a mid-year triggering event, or preparing for your first post-acquisition impairment test, Synpact Consulting delivers audit-ready analyses under IAS 36, ASC 350, or both — fast, accurately, and at a fraction of Big Four cost.

📞 Phone: (+91) 892-622-7979
📧 Email: [[email protected]]
📍 Office: 2nd Floor, Sri Sai Nagar, OMP Cuttack, Odisha – 753004, India
🕐 Hours: Monday to Friday, 9:30 AM – 6:30 PM IST
🔗 Book Your Free Strategy Call →

Synpact Consulting is a specialist financial valuation and advisory outsourcing firm based in India, serving clients across the United States, United Kingdom, and Australia. Our valuation services cover the complete spectrum — from goodwill & intangible impairment testing and financial reporting valuations to M&A transaction valuations, investment banking support, private equity services, and outsourced CFO solutions. Audit-ready. 48-hour delivery. Delivered by certified analysts.